Evidence map›Paper›PMID 39836325›Full record

ArticleApplied microbiology and biotechnology2025

Screening of high glucose tolerant Escherichia coli for L-valine fermentation by autonomous evolutionary mutation.

Li Zhang, Zhijie Cheng, Jing Jiang, Xinyu Zhou, Longjun Han, Lei Yang, Jian Gao

Abstract read
In one paragraph

Article in Applied microbiology and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Li ZhangCollege of Marine and Bioengineering, Yancheng Institute of Technology, Yancheng, 224051, PR China.ORCID http://orcid.org/0000-0002-6774-2733
Zhijie ChengCollege of Marine and Bioengineering, Yancheng Institute of Technology, Yancheng, 224051, PR China.
Jing JiangCollege of Marine and Bioengineering, Yancheng Institute of Technology, Yancheng, 224051, PR China.
Xinyu ZhouCollege of Marine and Bioengineering, Yancheng Institute of Technology, Yancheng, 224051, PR China.
Longjun HanCollege of Marine and Bioengineering, Yancheng Institute of Technology, Yancheng, 224051, PR China.
Lei YangCollege of Marine and Bioengineering, Yancheng Institute of Technology, Yancheng, 224051, PR China.
Jian GaoCollege of Marine and Bioengineering, Yancheng Institute of Technology, Yancheng, 224051, PR China. gaojian@ycit.edu.cn.

Funding

China Postdoctoral Science Foundation Grant No. 2019M661727National Natural Science Foundation of China Grant No. 22108234
6 · The paper itself

Abstract

L-valine holds wide-ranging applications in medicine, food, feed, and various industrial sectors. Escherichia coli, a pivotal strain in industrial L-valine production, features a concise fermentation period and a well-defined genetic background. This study focuses on mismatch repair genes (mutH, mutL, mutS, and recG) and genes associated with mutagenesis (dinB, rpoS, rpoD, and recA), employing a high-glucose adaptive culture in conjunction with metabolic modifications to systematically screen for superior phenotypes. This approach enhances the spontaneous survival rate of stress cells and facilitates the enrichment of positive mutations. Leveraging a multi-fragment seamless recombination technique, we successfully assembled the ilvBN, ilvC, ilvE, and ilvD pathway enzyme genes, transforming E. coli from a non-producer into a proficient L-valine producer capable of generating up to 6.62 g/L. Through a synergistic application of self-evolution engineering and metabolic engineering strategies, the engineered E. coli strain exhibited significantly enhanced tolerance and demonstrated heightened accumulation of L-valine. KEY POINTS: • The innovation centered on mutated genes and mismatch repair genes • By integrating modification with adaptive culture, a superior phenotype was attained • Double plasmids expressing enzymes for L-valine production in E. coli were obtained.

Indexed as

Escherichia coliGlucoseMetabolic EngineeringValineDNA Mismatch RepairEscherichia coli ProteinsFermentationMutagenesisMutationEscherichia coli ProteinsGlucoseValineE. coliGlucose toleranceL-valineMetabolic modificationSurvival rate

Identifiers

PMID39836325
PMCPMC11750901

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.